Dillon & Associates’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2020
Q4 | – | Sell |
-1,031
| Closed | -$293K | – | 67 |
|
2020
Q3 | $293K | Sell |
1,031
-320
| -24% | -$90.9K | 0.07% | 58 |
|
2020
Q2 | $362K | Hold |
1,351
| – | – | 0.1% | 53 |
|
2020
Q1 | $427K | Sell |
1,351
-100
| -7% | -$31.6K | 0.14% | 52 |
|
2019
Q4 | $431K | Sell |
1,451
-425
| -23% | -$126K | 0.12% | 53 |
|
2019
Q3 | $437K | Sell |
1,876
-930
| -33% | -$217K | 0.13% | 51 |
|
2019
Q2 | $657K | Sell |
2,806
-60
| -2% | -$14K | 0.2% | 50 |
|
2019
Q1 | $676K | Buy |
2,866
+45
| +2% | +$10.6K | 0.22% | 47 |
|
2018
Q4 | $849K | Buy |
2,821
+105
| +4% | +$31.6K | 0.32% | 41 |
|
2018
Q3 | $959K | Buy |
2,716
+95
| +4% | +$33.5K | 0.32% | 40 |
|
2018
Q2 | $760K | Buy |
2,621
+397
| +18% | +$115K | 0.28% | 43 |
|
2018
Q1 | $609K | Buy |
2,224
+569
| +34% | +$156K | 0.24% | 48 |
|
2017
Q4 | $528K | Buy |
1,655
+185
| +13% | +$59K | 0.2% | 51 |
|
2017
Q3 | $460K | Buy |
1,470
+10
| +0.7% | +$3.13K | 0.18% | 53 |
|
2017
Q2 | $396K | Sell |
1,460
-325
| -18% | -$88.2K | 0.16% | 56 |
|
2017
Q1 | $487K | Buy |
1,785
+5
| +0.3% | +$1.36K | 0.21% | 55 |
|
2016
Q4 | $506K | Buy |
1,780
+40
| +2% | +$11.4K | 0.23% | 53 |
|
2016
Q3 | $545K | Buy |
1,740
+60
| +4% | +$18.8K | 0.25% | 52 |
|
2016
Q2 | $407K | Buy |
1,680
+245
| +17% | +$59.4K | 0.19% | 56 |
|
2016
Q1 | $373K | Buy |
1,435
+265
| +23% | +$68.9K | 0.17% | 56 |
|
2015
Q4 | $358K | Buy |
1,170
+65
| +6% | +$19.9K | 0.17% | 55 |
|
2015
Q3 | $323K | Buy |
1,105
+203
| +23% | +$59.3K | 0.16% | 59 |
|
2015
Q2 | $364K | Buy |
902
+157
| +21% | +$63.4K | 0.18% | 54 |
|
2015
Q1 | $314K | Buy |
745
+45
| +6% | +$19K | 0.15% | 56 |
|
2014
Q4 | $237K | Sell |
700
-45
| -6% | -$15.2K | 0.12% | 60 |
|
2014
Q3 | $247K | Hold |
745
| – | – | 0.13% | 60 |
|
2014
Q2 | $234K | Hold |
745
| – | – | 0.12% | 58 |
|
2014
Q1 | $228K | Hold |
745
| – | – | 0.12% | 58 |
|
2013
Q4 | $209K | Buy |
+745
| New | +$209K | 0.11% | 59 |
|